Back to search

Article

Prolactin Receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in Acute Myeloid Leukemia

2022-05-31

Abstract excerpt

<h4>Background: </h4> Development of precision medicine requires the identification of easily detectable and druggable biomarkers. Despite recent targeted drug approvals, prognosis of acute myeloid leukemia (AML) patients needs to be greatly improved, as relapse and refractory disease are still difficult to manage. Thus, new therapeutic approaches are needed. Based on in silico -generated preliminary data and the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8352605f-8bb3-576e-abbe-b9608029570a
DOI
10.21203/rs.3.rs-1688278/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prolactin Receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in Acute Myeloid LeukemiaDOI 10.21203/rs.3.rs-1688278/v1
Select a neighboring publication to make it the new centre.